| 1 | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. (Sourianarayanane A, Garg G, Smith TH, Butt MI, McCullough AJ, Shen B) J Crohns Colitis 2013 Sep;7(8):e279-85 127 Citations |
| 1 | Alcohol in Non-Alcoholic Fatty Liver Disease: An Oxymoron or a New Standard of Care? (Sourianarayanane A, Dasarathy S, Mccullough AJ) Non Alcoholic Fatty Liver Disease A Practical Guide 8 March 2013:234-247 |
| 1 | Management of non-alcoholic fatty liver disease. (Sourianarayanane A, Pagadala MR, Kirwan JP) Minerva Gastroenterol Dietol 2013 Mar;59(1):69-87 11 Citations |
| 1 | Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. (Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough AJ, Dasarathy S) Liver Int 2015 Mar;35(3):979-85 111 Citations |
| 1 | The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. (Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ) J Gastroenterol Hepatol 2016 May;31(5):995-1000 23 Citations |
| 1 | Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. (Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai RK, Dasarathy S, McCullough AJ) BBA Clin 2015 Jun;3:141-5 56 Citations |
| 1 | Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. (Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, Ramanathan S) Cytokine 2016 Jun;82:102-11 62 Citations |
| 1 | Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. (Rao PK, Merath K, Drigalenko E, Jadhav AYL, Komorowski RA, Goldblatt MI, Rohatgi A, Sarzynski MA, Gawrieh S, Olivier M) Clin Proteomics 2018;15:10 24 Citations |
| 1 | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. (Ren SM, Mei L, Huang H, Cao SF, Zhao RH, Zheng PY) Zhonghua Gan Zang Bing Za Zhi 2019 May 20;27(5):369-375 |
| 1 | The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. (Motamed N, Nikkhah M, Karbalaie Niya MH, Khoonsari M, Perumal D, Ashrafi GH, Faraji AH, Maadi M, Ajdarkosh H, Safarnezhad Tameshkel F, Moradi-Lakeh M, Miri SM, Arsang-Jang S, Zamani F) Clin Res Hepatol Gastroenterol 2021 Nov;45(6):101567 20 Citations |
| 1 | Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. (Kichloo A, Solanki S, Haq KF, Dahiya D, Bailey B, Solanki D, Singh J, Albosta M, Wani F, Aljadah M, Shah H, Khan H, Jafri SM) World J Gastrointest Pathophysiol 2021 Mar 22;12(2):14-24 |
| 1 | Role of Fasting in the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Review of Clinical Trials. (Haddad RR, Battula NS, Chay T, Patel T, Dumaru N, Maddukuri S, Khan S) Cureus 2025 May;17(5):e84259 |
